Even though NVMe has been out for over a decade, Windows still classifies these newer, drastically faster storage devices the ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Security defenders are girding themselves in response to the disclosure of a maximum-severity vulnerability disclosed Wednesday in React Server, an open-source package that’s widely used by websites ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

KnownHost may be a smaller host, but it generally gets more positive feedback than larger competitors. Reliable technical support, fast server speeds and helpful customer service are frequently ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

Update, August 8: After apparent confirmation that Battlefield 6 would fill half-empty servers with bots, EA has offered some "clarification on AI Soldiers within Open Beta." For now, you'll only see ...